Executive summaries on hypertension II. Choices of initial drug therapy

Norman M Kaplan

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Once the need for drug therapy has been determined, the JNC-6 report provides three pathways for the choice of therapy: for uncomplicated patients, a diuretic or β-blocker; for patients with diabetic nephropathy, isolated systolic hypertension, congestive heart failure or systolic dysfunction after myocardial infarction, specific drugs are compellingly indicated; for other conditions, certain drugs that provide favorable effects are recommended. Whatever drug is chosen, long-acting preparations that provide 24-h coverage with one daily dose are recommended.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalDrugs of Today
Issue number1
StatePublished - 1998

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Executive summaries on hypertension II. Choices of initial drug therapy'. Together they form a unique fingerprint.

Cite this